Exchange: NASDAQ·Updated 12:08 PM EDT
EVMN logo

EVMN Evommune Inc

$14.19
$0.52
(3.80%)
Today
Mkt Cap$496.11M
Vol156,803.00

About EVMN

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.
38

Bearish Sentiment

How do you feel about EVMN?

Advertisement|Remove ads.